Encompass Health Corporation – Consensus Indicates Potential 36.9% Upside
Encompass Health Corporation found using ticker (EHC) have now 12 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 78 and 59 calculating the average target price we see 65.33. Now with the previous closing price of 47.72 this indicates there is a potential upside of 36.9%. The day 50 moving average is 50.72 and the 200 day moving average is 51.25. The company has a market cap of $4,686m. Find out more information at: https:||www.encompasshealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EHC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $6,415m based on the market concensus. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Encompass Health Corporation – Consensus Indicates Potential 36.9% Upside
Encompass Health Corporation found using ticker (EHC) have now 12 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 78 and 59 calculating the average target price we see 65.33. Now with the previous closing price of 47.72 this indicates there is a potential upside of 36.9%. The day 50 moving average is 50.72 and the 200 day moving average is 51.25. The company has a market cap of $4,686m. Find out more information at: https:||www.encompasshealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EHC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $6,415m based on the market concensus. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.